Skip to main content
Clinical Trials/NCT01838798
NCT01838798
Completed
Not Applicable

Neuropsychological Impact of Hospitalization on Intubated, Ventilated and Sedated ICU Patients

Centre Hospitalier Universitaire de Nīmes1 site in 1 country125 target enrollmentNovember 1, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stress Disorders, Post-Traumatic
Sponsor
Centre Hospitalier Universitaire de Nīmes
Enrollment
125
Locations
1
Primary Endpoint
Presence/absence of cognitive impairment
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

This is a prospective, single-center, pilot, cohort study. The first phase of this study is observational and the usual care of patients is maintained during the ICU stay, except for an interview with a psychologist preceding patient discharge. A phone interview at 2 months and a visit with a psychologist at four months after ICU discharge are specific to the study.

The main objective of this study is to make a first estimate of the percentage of patients (CI = +- 10%) with cognitive impairment at four months after ICU discharge. The presence / absence of cognitive impairment will be determined by the D2 test.

Detailed Description

The secondary objectives of this study are: A. To study the potential links between cognitive impairment and quality of life 4 months after discharge from the Intensive Care Unit. B. To study the associations between variables measured during hospitalization. Is there "clustering" among certain symptoms during hospitalization? C. To study the associations between variables measured at two and four months after ICU discharge. Is there clustering among these symptoms? D. To study potential risk factors for cognitive problems at 4 months after ICU discharge. E. If objective C determines the presence of clusters, is the presence / absence of these clusters related to the variables (or clusters of variables) measured during hospitalization? F. To study potential risk factors for poor quality of life at 4 months:

Registry
clinicaltrials.gov
Start Date
November 1, 2013
End Date
October 1, 2016
Last Updated
4 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The patient (or his/her "trusted person") must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for a telephone interview at 2 months after ICU discharge, and for a follow-up visit at 4 months after ICU discharge
  • Patient admitted to the ICU and intubated and ventilated for at least 48 hours

Exclusion Criteria

  • The patient is currently participating in or has participated in another study (within the past 3 months) that might influence the results of the current study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient is pregnant, parturient, or breastfeeding
  • The patient has a contra-indication for a treatment used in this study
  • Patient admitted to intensive care with sedation started for more than 24 hours
  • Patient with neurological or psychiatric (cognitive) disorders
  • Patient admitted for cardiac arrest
  • Patient admitted for stroke

Outcomes

Primary Outcomes

Presence/absence of cognitive impairment

Time Frame: 4 months after ICU discharge

based on D2 test

Secondary Outcomes

  • Test D2 (units = n)(4 months after ICU discharge)
  • Wisconsin test(4 months after ICU discharge)
  • ICU-SEQ questionnaire(60 +- 3 days after ICU discharge)
  • IDS-C Questionnaire(4 months after ICU discharge)
  • Questionnaire PDEQ-10(expected average of 5 days (end of ICU stay))
  • Assessment of psychotramatisme(60 +- 3 days after ICU discharge)
  • Daily average for Behaviour pain scale(expected average of 48 hours)
  • CAM ICU score(upon awakening (expected average of 48 hours))
  • Peritraumatic distress inventory(expected average of 5 days (end of ICU stay))
  • Backwards span test(4 months after ICU discharge)
  • Duration of sedation(expected average of 48 hours)
  • Assessment of potential impacts(expected average of 5 days (end of ICU stay))
  • HADS score(60 +- 3 days after ICU discharge)
  • Stroop test(4 months after ICU discharge)
  • ICUMT questionnaire(60 +- 3 days after ICU discharge)
  • PCLS scale (DSM IV items)(4 months after ICU discharge)
  • SF-36(4 months after ICU discharge)
  • Forward span test(4 months after ICU discharge)
  • Rey 15-word test(4 months after ICU discharge)
  • Duration of ventilation(expected average of 36 hours)
  • Daily average for RASS scale(Expected maximum of 28 days)
  • Verbal fluency test(4 months after ICU discharge)

Study Sites (1)

Loading locations...

Similar Trials